Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01106313 · ClinicalTrials.gov registry record
Insulin Resistance in Patients With Major Depression
A clinical trial of Depression and Bipolar Disorder, sponsored by Stanford University.
- Completed
- Registry status
- 57
- Enrollment target
- 1
- Study location
NCT01106313: Completed study of Depression and Bipolar Disorder, sponsored by Stanford University.
NCT01106313 is a study of Depression and Bipolar Disorder that has completed, run by Stanford University. The registered enrollment target is 57 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01106313, a study of Depression and Bipolar Disorder, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 57 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to study the relationship between insulin and glucose action and neuropsychological functioning (memory, attention, general thinking abilities) in persons with depression.
Conditions Studied
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2009-07 |
| Est. Completion | 2016-01 |
What the finished NCT01106313 record still lists
NCT01106313 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (93% lower).
The record links to 6 conditions, with Depression appearing as the primary indexed condition, and to 0 interventions.
NCT01106313 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01106313 about?
NCT01106313 is a clinical study titled "Insulin Resistance in Patients With Major Depression". The purpose of this study is to study the relationship between insulin and glucose action and neuropsychological functioning (memory, attention, general thinking abilities) in persons with depression.
What is the current status of trial NCT01106313?
This trial is currently completed. The enrollment target is 57 participants. The study started on 2009-07. Estimated completion is 2016-01.
What conditions does trial NCT01106313 study?
This clinical trial studies the following conditions: Depression, Bipolar Disorder, Insulin Resistance, Depressive Disorder, Major, Depressive Disorder.
Who is sponsoring clinical trial NCT01106313?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01106313 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01106313's enrollment target sits among peer trials
57 451st of 679 higher than 227 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Depression and Driving
RECRUITING
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia